552331-30-3 Usage
General Description
5-bromo-1,3-dimethyl-1H-indazole is a chemical compound with the molecular formula C9H9BrN2. It is a derivative of indazole, a bicyclic heterocycle that consists of a benzene ring fused to a five-membered nitrogen-containing ring. 5-bromo-1,3-dimethyl-1H-indazole is commonly used in pharmaceutical research and drug development due to its potential biological activities. It has been studied for its antimicrobial, antifungal, and antiviral properties, as well as its potential applications in cancer treatment. Additionally, 5-bromo-1,3-dimethyl-1H-indazole has been investigated for its potential use as a building block in organic synthesis, particularly in the development of novel pharmaceutical compounds. Overall, this chemical compound holds promise for various applications in the fields of medicine and chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 552331-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,2,3,3 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 552331-30:
(8*5)+(7*5)+(6*2)+(5*3)+(4*3)+(3*1)+(2*3)+(1*0)=123
123 % 10 = 3
So 552331-30-3 is a valid CAS Registry Number.
552331-30-3Relevant articles and documents
HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY
-
Page/Page column 51, (2021/02/26)
A compound of formula (I) useful in the treatment of a Pneumoviridae viral infection.
CONDENSED PYRIMIDINE OR PYRIDAZINE DERIVATIVES AS ANTIVIRAL AGENTS
-
Page/Page column 34; 38, (2020/05/19)
A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is a prodrug of a PI4KIIIβinhibitor and as such is useful as an antiviral agent. A pharmaceutical composition comprising the compound.
THIADIAZINE DERIVATIVES
-
Page/Page column 35; 41, (2020/02/06)
The invention relates to thiadiazine derivatives, or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof, as well as to pharmaceutical compositions containing